Family

+

−

Country	kind	publication No.	Filing Date	Type	Sub-Type
GB	D0	GB201309178	May 21, 2013	Patent	Application
Type : Patent Sub-Type : Application
Patent application filed (unpublished application)		Enzyme and uses thereof		Jan 01, 1970
WO	A1	WO2014188163	May 16, 2014	Patent	Application
Type : Patent Sub-Type : Application
INTERNATIONAL APPLICATION PUBLISHED WITH INTERNATIONAL SEARCH REPORT		ENZYME AND USES THEREOF		Nov 27, 2014

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
UCL BUSINESS PLC	THE NETWORK BUILDING 97 TOTTENHAM COURT ROAD LONDON W1T 4TP

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• C12N:MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF
• C07K:PEPTIDES

• 2014 Application Filing Year
• A61K Class
• 14144 Applications Filed
• 11600 Patents Issued To-Date
• 82.02 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Negus, David	London, GB	1	1
# of filed Patents : 1 Total Citations : 1
Taylor, Peter	Billingshurst, GB	33	483
# of filed Patents : 33 Total Citations : 483

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 1 Citation Count
• A61K Class

• 38.16 % this patent is cited more than
• 9 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Oct 28, 2027

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2016/0115,466

ENZYME AND USES THEREOF

---

Abstract

---

The present invention relates generally to methods and materials relating to newly characterised enzymes from Pusillimonas noertemannii, or variants thereof, capable degrading poly-γ-D-glutamic acid, for example as is present in the capsule of B. anthracis. Such depolymerases have utility as therapeutics.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.